Global Aid Cuts Threaten AIDS, TB, Malaria Fight – What It Means for Nigeria
Peter Sands, head of the Global Fund to Fight AIDS, Tuberculosis and Malaria, warned that cuts in international aid financing are already affecting efforts against the three diseases, with health outcomes likely to worsen in coming years unless funding is restored. Speaking to reporters, Sands said while countries have shifted resources to cover immediate life-saving treatment, longer‑term activities such as training, capacity building and infrastructure development have been deprioritised. The Global Fund disbursed about $5.3 billion during the 2024‑26 period, but major donors including the United States and Britain have reduced their contributions. Sands expressed particular concern about malaria, which the World Health Organization estimates kills more than 600,000 people annually and for which spending was already inadequate. He noted that since 2002 the Fund’s interventions have saved 72 million lives and cut the combined death rate from AIDS, TB and malaria by 65 percent.
For Nigeria, which carries a significant share of the global malaria, TB and HIV/AIDS burden, reduced external aid could mean fewer insecticide‑treated nets, antiretroviral drugs and TB diagnostics reaching communities already strained by domestic health financing gaps. The warning underscores the need for Nigeria to examine how it can sustain disease control programmes if external support continues to decline.
What mix of increased domestic health spending, innovative financing mechanisms and stronger partnership with African institutions could help Nigeria maintain progress against AIDS, TB and malaria amid shrinking global aid?